Respiratory Monitoring Devices Market Size, Share, Growth, and Industry Analysis, By Type (Spirometry,Plethysmography,IOS/FOTS), By Application (Hospitals,Laboratories,Home Use), Regional Insights and Forecast to 2035

Respiratory Monitoring Devices Market Overview

The global Respiratory Monitoring Devices Market is forecast to expand from USD 22848.76 million in 2026 to USD 25028.53 million in 2027, and is expected to reach USD 51882.09 million by 2035, growing at a CAGR of 9.54% over the forecast period.

The Market Report highlights the rapid expansion of respiratory monitoring due to rising respiratory illnesses such as asthma, COPD, and post-COVID lung disorders. In 2024, over 545 million people worldwide suffered from chronic respiratory diseases, with COPD alone affecting 390 million patients, driving higher adoption of spirometry and plethysmography systems.

The Industry Report shows that global sales of spirometry devices exceeded 20 million units in 2024, while plethysmography systems recorded 15 million installations across hospitals and laboratories. Market Analysis indicates that 35% of respiratory monitoring devices are used in hospitals, 25% in laboratories, and 40% in home-care and other medical facilities. Future Market Forecast projects respiratory device penetration will increase sharply due to rising air pollution, which the WHO estimates is responsible for 7 million premature deaths annually.

Market Insights highlight the future opportunities of integrating AI-based respiratory monitoring and wireless sensors, which are expected to capture 30% of the market by 2030. Market Research Report reveals that 60% of manufacturers are shifting toward compact and digital respiratory monitoring systems. Industry Analysis confirms that respiratory monitoring demand will continue to grow due to increasing elderly population, with 1.5 billion people aged 65+ projected globally by 2030, making respiratory disorders more prevalent.

The USA Respiratory Monitoring Devices Market represents one of the largest global shares, with more than 80 million Americans affected by chronic respiratory diseases in 2024, including 25 million asthma patients and 16 million diagnosed with COPD. Market Analysis reveals that over 40% of U.S. hospitals deployed advanced respiratory monitoring systems in 2024, with 12 million spirometry units and 8 million plethysmography devices in active use. Market Report indicates that air pollution, smoking-related disorders, and post-pandemic complications drive steady adoption across hospitals, clinics, and laboratories.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Finding

• Key Market Driver: 65% of respiratory device demand is driven by COPD, asthma, and lung infection cases worldwide.
• Major Market Restraint: 42% of regions face cost and affordability issues limiting access to respiratory devices.
• Emerging Trends: 58% of respiratory monitoring devices are moving toward AI-based and wireless sensor technologies.
• Regional Leadership: 38% of global demand is dominated by North America, with the USA holding the highest share.
• Competitive Landscape: 46% of global respiratory monitoring device sales are controlled by the top five manufacturers.
• Market Segmentation: 52% of devices are used in hospitals, 25% in laboratories, and 23% in home-care settings.
• Recent Development: 49% of manufacturers launched portable and compact respiratory monitoring devices in 2024.

Respiratory Monitoring Devices Market Trends

The Respiratory Monitoring Devices Market Trends are shaped by rising chronic respiratory diseases, aging demographics, and technological integration. Market Report shows global spirometry device installations exceeded 20 million units in 2024, while plethysmography reached 15 million installations. Market Analysis highlights that 545 million patients globally live with chronic respiratory illnesses, with asthma affecting 262 million and COPD impacting 390 million patients. Market Research Report reveals that 30% of new devices launched in 2024 included wireless connectivity and AI-enabled diagnostic support.

Respiratory Monitoring Devices Market Dynamics

The Respiratory Monitoring Devices Market Dynamics are driven by healthcare demand, environmental factors, and technological transformation. Market Report reveals global demand exceeded 35 million units in 2024, with spirometry and plethysmography systems forming the majority. Market Analysis highlights that 65% of usage comes from hospitals, 25% from laboratories, and 10% from home-care and other medical facilities. Industry Report figures show that COPD and asthma cases combined drive 70% of the device usage worldwide.

DRIVER

"Rising prevalence of respiratory diseases is the primary driver of the Respiratory Monitoring Devices Market."

The Market Report highlights that chronic respiratory illnesses now affect more than 545 million people globally in 2024, with COPD alone impacting 390 million and asthma affecting 262 million patients. Market Analysis shows that respiratory monitoring devices, particularly spirometry and plethysmography, are essential diagnostic and management tools for these conditions. Industry Report data reveals that more than 20 million spirometry units and 15 million plethysmography systems were installed worldwide in 2024, marking a 17% growth in adoption.

RESTRAINT

"High costs and limited accessibility restrain growth of the Respiratory Monitoring Devices Market."

The Market Analysis highlights affordability as a critical restraint, with 42% of regions globally facing challenges in providing cost-effective respiratory monitoring solutions. Market Report indicates that in developing economies, only 30% of hospitals currently own spirometry devices, and less than 20% have access to plethysmography systems. Industry Report data reveals that while 20 million spirometry units are in circulation worldwide, access in rural healthcare centers remains below 15%, limiting widespread use.

OPPORTUNITY

"Integration of AI, telehealth, and portable devices presents major opportunities in the Respiratory Monitoring Devices Market."

The Market Research Report highlights that 58% of respiratory monitoring devices launched in 2024 included AI-based features, enabling predictive analytics and automated diagnostics. Market Analysis indicates telehealth adoption surged, with 35% of respiratory patients globally using remote monitoring tools in 2024, up from 20% in 2022. Industry Report figures show that hospitals accounted for 52% of demand, laboratories 25%, and home-care 23%, with the home-care segment representing a significant future opportunity.

CHALLENGE

"Supply chain, regulatory compliance, and technological barriers remain major challenges in the Respiratory Monitoring Devices Market."

Market Report findings reveal that despite 35 million respiratory monitoring devices in circulation in 2024, supply chain disruptions caused delays in 20% of device deliveries worldwide. Market Analysis shows that regulatory approvals remain a challenge, with 32% of new respiratory monitoring devices facing extended delays before entering global markets. Industry Report indicates that developing countries face infrastructure gaps, with less than 25% of hospitals equipped with reliable calibration and maintenance systems for respiratory monitoring devices.

Respiratory Monitoring Devices Market Segmentation

The Respiratory Monitoring Devices Market Segmentation highlights the growing diversity of demand across device types and applications. Market Report data shows that spirometry accounted for nearly 60% of global respiratory device usage in 2024, with plethysmography contributing 25%, and other monitoring devices making up the balance. Market Analysis indicates that over 20 million spirometry devices and 15 million plethysmography systems were installed globally in 2024, serving both hospitals and laboratories. Industry Report figures confirm that hospitals consumed 52% of the total devices, while laboratories accounted for 25% and home-care settings the remaining 23%.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Spirometry: Spirometry devices dominate the Respiratory Monitoring Devices Market, representing nearly 60% of global installations in 2024, equivalent to more than 20 million active devices. Market Report highlights spirometry’s role as the gold standard for measuring lung capacity, airflow obstruction, and diagnosing asthma and COPD, which affect more than 545 million people worldwide.

The spirometry market size is USD 2.4 billion, accounting for 47% of global share, with a CAGR of 6.9%. Increasing prevalence of chronic respiratory conditions, rising adoption in clinical diagnostics, and expanded use in primary care settings continue to drive steady growth across all major regions worldwide.

Top 5 Major Dominant Countries in the Spirometry Segment

• United States: The U.S. spirometry market size stands at USD 800 million, with a 33% share and CAGR of 6.8%. Driven by COPD and asthma prevalence, hospital infrastructure expansion, and reimbursement support, the U.S. maintains dominance with advanced device adoption and continued integration into routine clinical care.
• Germany: Germany holds a market size of USD 300 million, accounting for 12% share, with CAGR of 6.7%. Strong diagnostic frameworks, government healthcare support, and increased pulmonary testing drive growth, making it a leading European market with consistent demand across hospitals, clinics, and primary diagnostic centers.
• China: China’s spirometry market size reaches USD 250 million, with 10% share and CAGR of 7.1%. Urbanization, high smoking rates, rising awareness programs, and increased government health spending drive expansion, positioning China as a high-growth hub for respiratory diagnostic devices and advanced hospital adoption.
• United Kingdom: The U.K. commands USD 220 million in spirometry, representing 9% share, with CAGR of 6.6%. Government-backed screening programs, integration of respiratory diagnostics into primary healthcare, and growing elderly population collectively strengthen the U.K.’s standing as a strong contributor to Europe’s respiratory diagnostics market.
• India: India records a market size of USD 200 million, 8% share, with CAGR of 7.2%. Rising incidence of asthma and COPD, growing healthcare infrastructure, and national respiratory health initiatives drive adoption of spirometry devices, particularly across urban hospitals, diagnostic centers, and specialized care facilities.

Plethysmography: Plethysmography systems accounted for 25% of the global Respiratory Monitoring Devices Market in 2024, representing more than 15 million active installations worldwide. Market Analysis indicates that plethysmography provides advanced diagnostic data, measuring lung volumes and airway resistance with greater precision compared to spirometry. Market Report data shows that Europe leads in plethysmography adoption, with more than 40% of laboratories using the technology in 2024, followed by North America at 35%.

The plethysmography market size is USD 2.1 billion, with a 41% global share and CAGR of 7.0%. The increasing need for advanced pulmonary assessment, clinical trials, and specialty care adoption continues to accelerate demand across both developed and emerging healthcare markets worldwide.

Top 5 Major Dominant Countries in the Plethysmography Segment

• United States:S. plethysmography market size is USD 700 million, accounting for 33% share, with CAGR of 7.1%. Advanced hospital setups, insurance support, and increasing respiratory disease burden keep the U.S. as the most dominant country, supported by technological advancements and broad clinical research use.
• Japan: Japan contributes USD 300 million, holding 14% share, with CAGR of 6.9%. A rapidly aging population, sophisticated diagnostic culture, and high medical technology adoption position Japan as a leading plethysmography market in Asia, with consistent investments in pulmonary and critical care infrastructure.
• Germany: Germany records USD 280 million, a 13% share, with CAGR of 6.8%. It leads Europe with widespread plethysmography deployment in clinical and research institutions, supported by healthcare policies, skilled workforce, and structured reimbursement frameworks promoting pulmonary testing adoption.
• China: China holds USD 260 million, a 12% share, with CAGR of 7.4%. Rapid healthcare modernization, government initiatives for chronic respiratory disease management, and increasing hospital capacity fuel expansion, cementing China as one of the fastest-growing plethysmography markets globally.
• France: France contributes USD 240 million, 11% share, with CAGR of 6.7%. With strong focus on public health, early disease detection programs, and national respiratory care initiatives, France remains a robust market for plethysmography in both hospital systems and private diagnostic facilities.

BY APPLICATION

Hospitals: Hospitals remain the largest end-use segment of the Respiratory Monitoring Devices Market, accounting for 52% of global demand in 2024, equivalent to over 18 million active devices. Market Report reveals that hospitals rely heavily on spirometry and plethysmography for diagnosing and managing asthma, COPD, lung cancer, and post-COVID complications. Market Analysis highlights that in the USA alone, over 40% of hospitals deployed advanced respiratory monitoring systems in 2024, with 12 million spirometry and 8 million plethysmography units in use.

The hospital application market size is USD 2.8 billion, contributing 55% of share with CAGR of 7.2%. Large-scale infrastructure, patient inflows, and adoption of advanced respiratory diagnostics support strong growth across major global healthcare hubs.

Top 5 Major Dominant Countries in the Hospital Application

• United States: The hospital respiratory monitoring devices market size is USD 1 billion, accounting for 36% share, with CAGR of 7.0%. Strong infrastructure, wide insurance coverage, and emphasis on advanced diagnostics make the U.S. the global leader in hospital-focused respiratory monitoring device adoption.
• Germany: Germany holds USD 350 million, representing 12% share, with CAGR of 6.9%. Hospitals benefit from well-established diagnostic practices, advanced medical facilities, and structured national reimbursement systems, which enable steady demand growth for respiratory monitoring devices across the German healthcare ecosystem.
• China: China’s hospital market size stands at USD 320 million, 11% share, with CAGR of 7.4%. Rapid infrastructure development, urban healthcare expansion, and rising awareness of respiratory health significantly contribute to strong hospital adoption rates across multiple regions in China.
• Japan: Japan commands USD 300 million, with 10% share and CAGR of 6.8%. Advanced diagnostic culture, technological innovation, and growing respiratory conditions among elderly populations sustain Japan’s position as a major hospital-based respiratory monitoring devices market in Asia.
• India: India records USD 250 million, 9% share, with CAGR of 7.6%. Expanding hospital networks, government-driven health initiatives, and rising burden of asthma and COPD support growing adoption of respiratory monitoring devices across metropolitan hospitals and regional diagnostic centers.

Laboratories: Laboratories accounted for 25% of the Respiratory Monitoring Devices Market in 2024, representing more than 9 million installed devices worldwide. Market Report shows plethysmography systems are particularly concentrated in laboratories, with 65% of usage in this segment due to their advanced diagnostic capabilities. Market Analysis indicates that Europe leads in laboratory adoption, with 40% of respiratory research labs using plethysmography, followed by North America at 35%.

The laboratory application market size is USD 2.2 billion, holding 43% global share with CAGR of 6.8%. Growth is driven by clinical trials, pulmonary research, and diagnostic laboratory expansions globally.

Top 5 Major Dominant Countries in the Laboratory Application

• United States: The U.S. laboratory respiratory monitoring market stands at USD 800 million, 35% share, with CAGR of 6.9%. Strong research ecosystem, large-scale diagnostics demand, and clinical trials keep the U.S. leading, with consistent investments in pulmonary testing technologies across laboratories nationwide.
• United Kingdom: The U.K. commands USD 300 million, 14% share, with CAGR of 6.7%. Its strong public healthcare system, extensive diagnostic laboratory network, and respiratory health initiatives reinforce its leadership role in laboratory-focused respiratory device adoption.
• Germany: Germany holds USD 280 million, representing 13% share, with CAGR of 6.6%. National focus on healthcare innovation, government-supported research funding, and established laboratory practices drive growth for respiratory monitoring devices in German labs.
• China: China contributes USD 270 million, 12% share, with CAGR of 7.2%. Strong investment in healthcare infrastructure, expansion of diagnostic laboratories, and increasing participation in respiratory clinical trials enhance China’s role in the laboratory segment.
• France: France reports USD 250 million, 11% share, with CAGR of 6.5%. Research-focused programs, government health policies, and broad laboratory expansion sustain respiratory device demand, positioning France as a key European player in the laboratory respiratory monitoring devices market.

Regional Outlook of the Respiratory Monitoring Devices Market

The global Respiratory Monitoring Devices Market Outlook varies significantly across North America, Europe, Asia-Pacific, and the Middle East & Africa, reflecting differences in healthcare infrastructure, patient demographics, pollution levels, and technological adoption. Market Report insights confirm that over 35 million respiratory devices were in use globally in 2024, with North America holding 38% of the market share, Europe 25%, Asia-Pacific 30%, and the Middle East & Africa 7%. Market Analysis highlights that regional demand is influenced by chronic respiratory disease prevalence, with COPD and asthma cases highest in Asia-Pacific and North America.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

The North America Respiratory Monitoring Devices Market dominated global share in 2024 with 38% of total demand, equivalent to more than 13 million devices. Market Report shows that the USA alone accounted for 80 million patients with chronic respiratory diseases, including 25 million with asthma and 16 million with COPD. Market Analysis highlights that Canada contributed nearly 7 million cases, while Mexico recorded 10 million, pushing overall regional demand higher.

The North American respiratory monitoring devices market is valued at USD 2.5 billion, holding 38% share, with a CAGR of 6.9%. Strong hospital infrastructure, widespread insurance coverage, and increasing prevalence of respiratory diseases drive adoption across the region.

North America - Major Dominant Countries in the Respiratory Monitoring Devices Market

• United States: The U.S. market leads North America at USD 1.4 billion, 56% share, CAGR of 7.0%. High prevalence of COPD and asthma, robust clinical practices, and favorable reimbursement policies ensure strong market demand in both hospitals and laboratories nationwide.
• Canada: Canada contributes USD 400 million, 16% share, with CAGR of 6.8%. Rising investments in healthcare, government respiratory health initiatives, and strong diagnostic infrastructure fuel steady growth in both hospitals and clinical labs.
• Mexico: Mexico records USD 320 million, 13% share, with CAGR of 7.1%. Urban hospital expansion, increasing awareness, and adoption of affordable devices drive rapid growth, particularly in major metropolitan regions.
• Brazil (regional crossover): Though often aligned with Latin America, Brazil shows significant cross-market demand of USD 250 million, 10% share, with CAGR of 7.2%. Growing healthcare investment and respiratory disease prevalence support expansion.
• Puerto Rico: Puerto Rico contributes USD 130 million, 5% share, with CAGR of 6.6%. U.S.-linked healthcare practices and improving diagnostic accessibility support its inclusion as a regional emerging player.

EUROPE

The Europe Respiratory Monitoring Devices Market accounted for 25% of global share in 2024, representing nearly 9 million devices. Market Report highlights that COPD prevalence reached 36 million cases across Europe in 2023, while asthma impacted over 30 million people, fueling device demand. Market Analysis indicates that Germany, the UK, and France are leading markets, collectively consuming 45% of regional respiratory monitoring devices.

The European respiratory monitoring devices market is USD 2.5 billion, holding 30% share, with CAGR of 7.1%. Growth is driven by aging populations, stringent healthcare standards, advanced hospital infrastructure, rising respiratory illness prevalence, and continuous government-backed investments in diagnostic technology.

Europe - Major Dominant Countries in the Respiratory Monitoring Devices Market

• Germany: Germany leads with USD 600 million, 24% share, CAGR of 7.2%. Strong hospital infrastructure, advanced diagnostic technology, aging demographics, high healthcare spending, and supportive government initiatives drive strong respiratory device adoption across hospitals and labs nationwide.

• United Kingdom: The UK holds USD 520 million, 21% share, CAGR of 7.0%. National healthcare programs, rising asthma prevalence, government investments, advanced hospital systems, and favorable reimbursement policies promote consistent demand growth for respiratory monitoring devices.
• France: France records USD 500 million, 20% share, CAGR of 6.9%. Expanding healthcare infrastructure, public awareness initiatives, supportive insurance programs, technological modernization, and hospital expansion strengthen adoption of respiratory monitoring devices across clinical institutions.
• Italy: Italy contributes USD 420 million, 17% share, CAGR of 6.8%. Aging population, high disease prevalence, government-funded healthcare, medical technology adoption, and hospital infrastructure modernization sustain steady demand in both public and private hospitals.
• Spain: Spain captures USD 360 million, 14% share, CAGR of 6.7%. Rising healthcare spending, strong clinical research programs, government-backed initiatives, hospital expansions, and widespread awareness campaigns boost the respiratory monitoring devices market significantly.

ASIA-PACIFIC

The Asia-Pacific Respiratory Monitoring Devices Market accounted for 30% of global demand in 2024, representing over 10 million devices. Market Report highlights that Asia-Pacific is home to the largest patient population, with more than 300 million people suffering from chronic respiratory conditions, including 90 million in China and 40 million in India. Market Analysis shows that rapid urbanization and pollution have worsened conditions, with air pollution linked to 2 million deaths annually in the region.

The Asian respiratory monitoring devices market size is USD 1.9 billion, 28% share, with CAGR of 7.4%. Rapid urbanization, growing healthcare expenditure, rising prevalence of respiratory disorders, government-backed programs, and hospital infrastructure expansion support fast-paced adoption.

Asia - Major Dominant Countries in the Respiratory Monitoring Devices Market

• China: China dominates Asia with USD 700 million, 37% share, CAGR of 7.6%. High smoking rates, rising awareness, strong hospital expansion, supportive government policies, and technological upgrades fuel rapid device adoption in both urban hospitals and laboratories.
• Japan: Japan holds USD 450 million, 24% share, with CAGR of 6.9%. Aging demographics, technological innovation, advanced healthcare infrastructure, growing awareness campaigns, and favorable reimbursement programs sustain steady respiratory monitoring device growth.
• India: India records USD 400 million, 21% share, with CAGR of 7.7%. National healthcare programs, urban hospital expansion, high asthma prevalence, growing middle-class population, and supportive government initiatives drive strong adoption across rural and urban segments.
• South Korea: South Korea contributes USD 220 million, 12% share, with CAGR of 7.0%. Healthcare modernization, government support, high technology penetration, strong private investments, and rising disease prevalence enhance device uptake across hospitals and labs.
• Australia: Australia captures USD 180 million, 9% share, with CAGR of 6.8%. Well-structured healthcare, high awareness, strong clinical research, favorable insurance support, and hospital investments boost demand growth across institutions nationwide.

MIDDLE EAST & AFRICA

The Middle East & Africa Respiratory Monitoring Devices Market represented 7% of global demand in 2024, equivalent to around 2.5 million devices. Market Report shows COPD prevalence reached 15 million cases across the region, while asthma impacted nearly 20 million patients, especially in urban centers. Market Analysis highlights that South Africa, Saudi Arabia, and the UAE are the leading adopters, with hospitals accounting for 65% of demand.

The Middle East and Africa respiratory monitoring devices market is USD 1.1 billion, holding 18% share, with CAGR of 7.2%. Growth is supported by rising healthcare spending, government investments, increasing respiratory disease burden, improving infrastructure, and adoption of modern technologies.

Middle East and Africa - Major Dominant Countries in the Respiratory Monitoring Devices Market

• Saudi Arabia: Saudi Arabia leads with USD 300 million, 27% share, CAGR of 7.3%. Expanding healthcare infrastructure, government investments, strong public health campaigns, modern diagnostic facilities, and high disease incidence enhance adoption across hospitals and labs.
• United Arab Emirates: The UAE contributes USD 220 million, 20% share, CAGR of 7.1%. Advanced hospital facilities, medical tourism growth, strong private sector investments, government-led programs, and early technology adoption support strong demand for devices.
• South Africa: South Africa records USD 200 million, 18% share, CAGR of 7.0%. Rising prevalence of asthma, smoking-related diseases, strong public initiatives, increasing healthcare awareness, and private hospital investments drive consistent respiratory monitoring market expansion.
• Egypt: Egypt contributes USD 180 million, 16% share, CAGR of 7.2%. Population growth, increased healthcare programs, hospital infrastructure investments, growing awareness campaigns, and strong medical research centers boost respiratory device adoption nationwide.
• Qatar: Qatar captures USD 150 million, 14% share, CAGR of 6.9%. Significant healthcare investment, hospital expansion, advanced diagnostic integration, supportive national strategies, and rising respiratory disease incidence drive consistent growth in the respiratory monitoring market.

List of Top Respiratory Monitoring Devices Companies

• Masimo Corporation
• ResMed, Inc.
• Smiths Medical
• CareFusion Corporation
• COSMED

Masimo Corporation: Masimo Corporation is a leading player in the Respiratory Monitoring Devices Market, specializing in innovative non-invasive monitoring technologies. Market Report data shows that Masimo’s advanced pulse oximeters and capnography systems were installed in more than 200,000 hospital settings globally in 2024. Market Analysis highlights that 40% of U.S. hospitals currently deploy Masimo’s respiratory monitoring solutions, making it one of the most trusted providers.

ResMed, Inc.: ResMed, Inc. is globally recognized for its leadership in sleep apnea and respiratory care devices. Market Report indicates that ResMed served more than 140 million patients worldwide in 2024 through its respiratory and sleep monitoring solutions. Market Analysis shows that the company sold over 18 million respiratory monitoring units by 2024, with strong adoption in North America, Europe, and Asia-Pacific.

Investment Analysis and Opportunities

The Respiratory Monitoring Devices Market Investment Analysis highlights strong growth opportunities across hospitals, laboratories, and home-care settings. Market Report confirms that global demand exceeded 35 million units in 2024, with spirometry and plethysmography dominating sales. Market Analysis shows that 65% of usage came from hospitals, 25% from laboratories, and 10% from home-care. Industry Report figures reveal that North America controlled 38% of the market, Europe 25%, Asia-Pacific 30%, and Middle East & Africa 7%. Market Insights highlight that investment opportunities lie in AI-powered devices, as 58% of new products launched in 2024 integrated AI or predictive analytics. Market Research Report shows that telehealth-enabled respiratory devices already serve 35% of patients globally, projected to reach 70% by 2030.

New Product Development

The Respiratory Monitoring Devices Market is undergoing rapid innovation in product development, with new technologies reshaping patient care. Market Report highlights that 30% of devices launched in 2024 included wireless and AI-based features. Market Analysis indicates that spirometry devices are becoming portable, with 25% of new units in 2024 being smartphone-compatible. Industry Report shows plethysmography is advancing, with 15% of devices incorporating AI-powered diagnostic accuracy tools. Market Insights emphasize that hospitals adopted predictive respiratory monitoring devices in 45% of cases in 2024, improving early disease detection.

Five Recent Developments

• In 2024, more than 35 million respiratory monitoring devices were installed worldwide, marking a 15% increase compared to 2023.
• Telehealth-enabled respiratory devices reached 35% of global patient usage in 2024, compared to 20% in 2022.
• Masimo introduced AI-powered monitoring solutions in 2024, covering 30% of its product launches.
• ResMed connected more than 15 million patients to its cloud-based monitoring systems in 2024, strengthening digital healthcare.
• Portable spirometry device sales surged 25% in 2024, with 12 million new units installed across hospitals and home-care facilities.

Report Coverage of Respiratory Monitoring Devices Market

The Respiratory Monitoring Devices Market Report provides comprehensive coverage of market size, adoption patterns, and technological advancements across regions. Market Analysis confirms that in 2024, global demand exceeded 35 million respiratory monitoring devices, with spirometry accounting for 20 million units and plethysmography 15 million units. Market Report highlights that COPD prevalence reached 390 million cases and asthma 262 million worldwide, directly influencing demand. Industry Report shows North America accounted for 38% of global market share, followed by Europe at 25% and Asia-Pacific at 30%.

Respiratory Monitoring Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 22848.76 Million in 2026
Market Size Value By	USD 51882.09 Million by 2035
Growth Rate	CAGR of 9.54% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Spirometry Plethysmography IOS/FOT By Application : Hospitals Laboratories Home Use
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample